checkAd
    Startseite > Aktien > Affimed > Nachrichten
    Affimed Aktie
    4,7050
     
    EUR
    +0,11 %
    +0,0050 EUR
    Letzter Kurs 29.04.24 Lang & Schwarz
    4,6400
     
    EUR
    1.286 STK
    Geldkurs 29.04.24
    4,7700
     
    EUR
    1.286 STK
    Briefkurs 29.04.24
    ISIN: NL0015001ZQ0 · WKN: A407ZR · Niederlande

    Neueste Nachrichten

    Affimed Announces 1-for-10 Reverse Stock Split
    06.03.24 · globenewswire · Affimed
    Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
    08.01.24 · globenewswire · Affimed
    Affimed Announces Leadership Change and Organizational Restructuring
    08.01.24 · globenewswire · Affimed
    Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
    03.01.24 · globenewswire · Affimed
    Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
    14.11.23 · globenewswire · Affimed
    Affimed Announces Acimtamig as International Nonproprietary Name for AFM13
    09.11.23 · globenewswire · Affimed
    Affimed to Report Third Quarter 2023 Financial Results & Corporate Update on November 14, 2023
    07.11.23 · globenewswire · Affimed
    Affimed Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
    03.11.23 · globenewswire · Affimed
    Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting
    02.11.23 · globenewswire · Affimed
    Affimed to Participate in Upcoming Investor Conferences
    01.11.23 · globenewswire · Affimed
    Affimed Announces Listing Transfer to Nasdaq Capital Markets
    04.10.23 · globenewswire · Affimed
    Affimed Announces Acceptance of an Abstract Comparing NK Cells Redirected by Innate Cell Engagers and CAR-NK Cells for Poster Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
    27.09.23 · globenewswire · Affimed